Vertex Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 397.36

VRTX Stock  USD 397.36  0.81  0.20%   
Vertex Pharmaceuticals' implied volatility is one of the determining factors in the pricing options written on Vertex Pharmaceuticals. Implied volatility approximates the future value of Vertex Pharmaceuticals based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Vertex Pharmaceuticals over a specific time period. For example, 2024-04-19 CALL at $397.5 is a CALL option contract on Vertex Pharmaceuticals' common stock with a strick price of 397.5 expiring on 2024-04-19. The contract was not traded in recent days and, as of today, has 3 days remaining before the expiration. The option is currently trading at a bid price of $3.7, and an ask price of $6.0. The implied volatility as of the 16th of April 2024 is 33.63. View All Vertex options

Closest to current price Vertex long CALL Option Payoff at Expiration

Vertex Pharmaceuticals' future price is the expected price of Vertex Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Vertex Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Vertex Pharmaceuticals Backtesting, Vertex Pharmaceuticals Valuation, Vertex Pharmaceuticals Correlation, Vertex Pharmaceuticals Hype Analysis, Vertex Pharmaceuticals Volatility, Vertex Pharmaceuticals History as well as Vertex Pharmaceuticals Performance.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.
At this time, Vertex Pharmaceuticals' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 7.46 in 2024, whereas Price To Sales Ratio is likely to drop 10.12 in 2024. Please specify Vertex Pharmaceuticals' target price for which you would like Vertex Pharmaceuticals odds to be computed.

Vertex Pharmaceuticals Target Price Odds to finish over 397.36

The tendency of Vertex Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 397.36 90 days 397.36 
about 98.0
Based on a normal probability distribution, the odds of Vertex Pharmaceuticals to move above the current price in 90 days from now is about 98.0 (This Vertex Pharmaceuticals probability density function shows the probability of Vertex Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Vertex Pharmaceuticals has a beta of 0.66. This entails as returns on the market go up, Vertex Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Vertex Pharmaceuticals will be expected to be much smaller as well. Additionally Vertex Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   Vertex Pharmaceuticals Price Density   

Predictive Modules for Vertex Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vertex Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vertex Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
33 Analysts
Estimates (0)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Vertex Pharmaceuticals. Your research has to be compared to or analyzed against Vertex Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Vertex Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Vertex Pharmaceuticals.

Vertex Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Vertex Pharmaceuticals is not an exception. The market had few large corrections towards the Vertex Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vertex Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vertex Pharmaceuticals within the framework of very fundamental risk indicators.
Alpha over NYSE Composite
Beta against NYSE Composite0.66
Overall volatility
Information ratio -0.13

Vertex Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vertex Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vertex Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Vertex Pharmaceuticals generated a negative expected return over the last 90 days
Vertex Pharmaceuticals is unlikely to experience financial distress in the next 2 years
Over 97.0% of the company outstanding shares are owned by institutional investors
Latest headline from TD Cowen says sickle cell therapies may get higher CMS payments

Vertex Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vertex Stock often depends not only on the future outlook of the current and potential Vertex Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vertex Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding260.5 M
Cash And Short Term Investments11.2 B

Vertex Pharmaceuticals Technical Analysis

Vertex Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Vertex Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vertex Pharmaceuticals. In general, you should focus on analyzing Vertex Stock price patterns and their correlations with different microeconomic environments and drivers.

Vertex Pharmaceuticals Predictive Forecast Models

Vertex Pharmaceuticals' time-series forecasting models is one of many Vertex Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vertex Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Vertex Pharmaceuticals

Checking the ongoing alerts about Vertex Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vertex Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Vertex Pharmaceuticals generated a negative expected return over the last 90 days
Vertex Pharmaceuticals is unlikely to experience financial distress in the next 2 years
Over 97.0% of the company outstanding shares are owned by institutional investors
Latest headline from TD Cowen says sickle cell therapies may get higher CMS payments
When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock:

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stocks Directory
Find actively traded stocks across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.